Clinical Trial Update: A Research Study of MK0633 in Patients With Chronic Obstructive Pulmonary Disease (COPD)(0633-009)(COMPLETED) [Phase 2]

View source ↗

Summary

The document reports the completion of a Phase 2 clinical trial of MK0633 in patients with chronic obstructive pulmonary disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• MK0633

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | Status: COMPLETED